Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





Program Evaluation: Developing and Implementing a Remediation Plan1							Updated April 30, 2021
																	Related Pages
					Return to Main Menu
PDF Versionpdf icon***Disclaimer:**The activities in this document are intended for example purposes only. The actual activities implemented as part of TB program evaluation should be identified by state or local TB program officials in collaboration with other stakeholders. The example provided here is not intended to be applied directly to any specific TB program.*TB programs can use program evaluation as an opportunity to improve the program through planning and implementation of remediation strategies based on program evaluation findings.1 A remediation plan will take your program evaluation results to the next step in continuous quality improvement.2
The first step in developing an actionable remediation plan is to review your program evaluation findings. For instance, the example program evaluation plan *Completion of Treatment for Tuberculosis Disease by Using Incentives and Enablers* includes a section on how the program evaluation findings will be used to address identified barriers. The remediation plan should build on the information included in the program evaluation report, going into more detail about actions and activities that will address the barriers identified through program evaluation.
An actionable remediation plan should include goals and objectives:On This Page
			GoalObjectivesResourcesGoalThe overall goal of a remediation plan is to address the areas where the TB program did not meet objectives and to implement strategies for long-term improvement in those areas. For example, our remediation plan goal for *Completion of Treatment for Tuberculosis Disease by Using Incentives and Enablers* should be based on addressing patient barriers for completing treatment using strategies that can be implemented long term.ObjectivesDeveloping objectives for your remediation plan will help to ensure that the activities meet the specific achievements that your program wants to accomplish. See *Developing Objectives and Evaluation Questions for TB Program Evaluation* for information about developing objectives that are Specific, Measurable, Achievable, Relevant, and Time bound (SMART).The goals and objectives should be followed by specific information about remediation plan activities, measures, timeline, dissemination of results and determining next steps. The table provides information about the elements that will help your program develop an action-oriented remediation plan.ActivitiesMeasuresTimelinePersons ResponsibleDissemination and Next StepsThese are specific activities that are decided upon by the TB program to address program evaluation findings. For example:
Program evaluation finding: many TB patients have a difficult time arriving at the TB clinic during normal clinic hours to receive Directly Observed Therapy (DOT)
Activity to address the finding: the TB program decides to partner with the STD clinic to offer extended hours and services for DOT of TB patientsYour plan should include measures to determine effectiveness of your activities. The criteria for each measure should be reasonable and quantifiable. For example:
The number of STD clinic staff cross-trained in administration of TB DOT
The number of TB patients who arrived at the STD clinic for TB DOT during extended clinic hours
The percentage of TB patients who completed therapy by DOTThe timeline should cover the time it will take to:
Implement new activities
Collect data to determine their effectiveness
Analyze and interpret data
Disseminate results of the remediation plan
Determine next stepsWhen developing a timeline, consider the following:
Reasonable timeframe: give a reasonable and feasible amount of time to complete each proposed activity
Resources: the TB program should have the necessary support (materials, staff, training, and collaboration) to implement and complete each activity
Accountability: regular communication between staff who are implementing activities, project lead, and other stakeholders on progress, barriers, and achievements of remediation plan activitiesAppoint a project lead to manage the implementation and monitoring of the remediation plan.
This person will be responsible for keeping the plan moving according to the timeline, addressing issues that come up, and adjusting the plan activities or timeline as needed.
The TB PEN focal point might be an excellent point person for the implementation of the remediation planList the activity leads who will manage the implementation and monitoring of specific activities in the remediation planDecide how you will disseminate results and determine next steps of your remediation plan. This may include reports to your program evaluation stakeholders.
Results can be disseminated informally in meetings or conference calls and formally through reports and presentations. See “Sharing Program Evaluation Findings” for more information and suggestions.
If you are required to submit an annual progress report to the Centers for Disease Control and Prevention’s Division of TB Elimination, be sure to include the progress and results of your remediation plan.Determine any next steps, such as policy or practice changes, other activities, or further evaluation based on your remediation plan findingsResources1For more information about using program evaluation findings and developing remediation plans:
Tuberculosis Elimination and Laboratory Cooperative Agreementexternal icon (See page 51 for a description of remediation plan structure)
Ensure Use of Evaluation Findings and Share Lessons Learned
Beyond Reporting: Getting More Value out of Your Evaluationexternal icon
Evaluation Toolkit: Improve Program with Evaluation Findingsexternal icon2For more information about quality improvement in public health:
Minnesota Department of Health: Continuous Quality Improvement Modelexternal icon
Centers for Disease Control and Prevention: Performance Management and Quality Improvement
Defining Quality Improvement in Public Health. Journal of Public Health Management and Practice. 2010:16(1); 5-7.external icon
							
					
						Page last reviewed:  April 27, 2021					Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue